Skip to main navigation Skip to search Skip to main content

A Prospective, Phase III, Open-Label Study of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects: Boceprevir, Interferon, Ribavirin to Treat HCV/HIV Coinfected Subjects (BIRTH)

Project: Research

Project Details

StatusFinished
Effective start/end date06/1/12 → 08/31/15

Funding

  • Social and Scientific Systems Incorporated: $180,511.14